Financings in Brief: Gliatech
This article was originally published in The Gray Sheet
Executive Summary
Gliatech: Files registration statement with the Securities and Exchange Commission for an initial public offering of 2.3 mil. shares of its common stock. Shares are expected to be sold for between $10 and $12 each, the company says. Gliatech manufactures the Adcon line of products to control surgical adhesion. The Cleveland, Ohio-based company currently is conducting U.S. clinical trials of its Adcon-L and Adcon-T/N gels, for prevention of adhesions in lumbar and tendon/peripheral nerve surgeries, respectively. Montgomery Securities, Vector Securities International, and McDonald & Company Securities will co-manage the offering, Gliatech says...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.